Jefferies Group's MDGL Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 2,300 shares of Madrigal Pharmaceuticals, Inc. (MDGL) worth $1.34 M, representing 0.01% of the portfolio. First purchased in 2023-Q1, this short-term holding has been held for 7 quarters.
Based on 13F filings, Jefferies Group has maintained this position in MDGL for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 2,300 shares. Largest reduction occurred in Q2 2023, reducing 1,079 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Madrigal Pharmaceuticals (MDGL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Madrigal Pharmaceuticals (MDGL) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2023 | +1,353 | New Buy | 1,353 | $242.26 |
| Q2 2023 | -1,079 | Reduce 79.75% | 274 | $231.00 |
| Q3 2023 | -274 | Sold Out | 0 | $0.00 |
| Q3 2024 | +352 | New Buy | 352 | $212.22 |
| Q4 2024 | -102 | Reduce 28.98% | 250 | $308.57 |
| Q1 2025 | -250 | Sold Out | 0 | $0.00 |
| Q4 2025 | +2,300 | New Buy | 2,300 | $582.34 |
Jefferies Group's Madrigal Pharmaceuticals Investment FAQs
Jefferies Group first purchased Madrigal Pharmaceuticals, Inc. (MDGL) in Q1 2023, acquiring 1,353 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Madrigal Pharmaceuticals, Inc. (MDGL) for 7 quarters since Q1 2023.
Jefferies Group's largest addition to Madrigal Pharmaceuticals, Inc. (MDGL) was in Q4 2025, adding 2,300 shares worth $1.34 M.
According to the latest 13F filing for Q4 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 2,300 shares of Madrigal Pharmaceuticals, Inc. (MDGL), valued at approximately $1.34 M.
As of the Q4 2025 filing, Madrigal Pharmaceuticals, Inc. (MDGL) represents approximately 0.01% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Madrigal Pharmaceuticals, Inc. (MDGL) was 2,300 shares, as reported at the end of Q4 2025.